Page last updated: 2024-12-06
trifluoroacetaldehyde hydrate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 67901 |
| SCHEMBL ID | 27246 |
| MeSH ID | M0071295 |
Synonyms (41)
| Synonym |
|---|
| 1,1-ethanediol, 2,2,2-trifluoro- |
| acetaldehyde, trifluoro-, hydrate |
| 2,2,2-trifluoroethanediol |
| nsc 146025 |
| einecs 207-006-4 |
| 2,2,2-trifluoro-1,1-ethanediol |
| brn 1736686 |
| fluoral, hydrate |
| nsc-146025 |
| 2,2-trifluoro-1,1-ethanediol |
| 1, 2,2,2-trifluoro- |
| acetaldehyde, hydrate |
| wln: qyqxfff |
| tfaih |
| wln: vhxfff &qh |
| 2,2-trifluoroacetaldehyde hydrate |
| fluoral hydrate |
| trifluoroacetaldehyde hydrate |
| 421-53-4 |
| nsc146025 |
| 2,2,2-trifluoroethane-1,1-diol |
| AKOS002662632 |
| 2,2,2-trifluoroethane-1,1-diol;2,2,2-trifluoro-1,1-ethanediol;2,2,2-trifluoroethanediol;fluoral hydrate |
| A825792 |
| FT-0632110 |
| T3654 |
| trifluoroacetaldehyde hydrate, tech., ca 75% in water |
| SCHEMBL27246 |
| DTXSID4059964 |
| J-506749 |
| trifluoracetaldehyd-hydrat |
| 2,2,2-trifluoro-1,1-ethanediol (contains total ca. 25% water) |
| BBL101718 |
| STL555515 |
| BCP05623 |
| 2,2,2-trifluoro-1,1-ethanediol (contains total ca. 35% water) |
| trifluoroacetaldehyde hydrate (tech.) |
| trifluoroacetaldehyde, solution |
| CS-0332345 |
| trifluoroethanal hydrate |
| DWG4394PJH |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 17.57
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.57) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (12.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||